Public Consultation on the Post-market Review of the Life Saving Drugs Program (LSDP)
Page last updated: 28 January 2018
Public Submissions: 11 August 2014 to 10 November 2014
The Call for Submissions addressing the Life Saving Drugs Program (LSDP) closed on 10 November 2014. The Department appreciates the contribution of all organisations and individuals who made a submission.
- The views expressed in submissions published on this website are solely those of the contributing authors or organisations.
- The Commonwealth accepts no responsibility for the completeness or accuracy of any information contained in the submissions.
- The Commonwealth makes no representations about the suitability of the information for any particular purpose. Users of the information must make their own inquires and assessments about those matters or seek independent advice.
- Submissions are published on the understanding that the contributing authors or organisations have copyright in the submissions either by way of ownership or a licence. They retain their copyright, and by making submissions they licence the Commonwealth to publish the submissions, unless a party when making a submission has requested that it be kept confidential and the Commonwealth clearly agrees that the submission will be kept confidential.
Subscribe to news updates for the latest information regarding reviews, including public consultation opportunities.
Unless otherwise requested, submissions addressing the Post-market Review of the Life Saving Drugs Program (LSDP) have been published below.
The Department of Health does not publish submissions, or parts of submissions, which contain personal information, offensive language, potentially defamatory material or copyright infringing material.
Responsibility for copyright in submissions resides with the author(s), not with the Department of Health.
All submissions have been converted to Portable Document Format (PDF) for publication and may have a different appearance to the document that was submitted.
Table of Submissions
|Submission||Author Name||Document Link||Date Received|
|1||Health Professional||Not for publication||23/09/2014|
|2||Dr James Gray||Submission 2 (PDF 53KB)||05/10/2014|
|3||Consumer||Submission 3 (PDF 106KB)||24/10/2014|
|4||Professor Jeffrey Szer||Submission 4 (PDF 357KB)||26/10/2014|
|5||Clinical Professor Jack Goldblatt||Submission 5 (PDF 63KB)||28/10/2014|
|6||Duchenne Foundation||Submission 6 (PDF 2.9MB)||04/11/2014|
|7||Australian Pompe’s Association||Submission 7 (PDF 3.6MB)||05/11/2014|
|8||Fabry Support Group Australia||Submission 8 (PDF 268KB)||07/11/2014|
|9||BioMarin Pharmaceutical Australia||Submission 9 (PDF 163KB)||07/11/2014|
|10||Dr David Ketteridge||Submission 10 (PDF 1.7MB)||07/11/2014|
|11||Gaucher Association of Australia||Not for publication||07/11/2014|
|12||Pfizer Australia||Submission 12 (PDF 2.5MB)||09/11/2014|
|13||Carer||Submission 13 (PDF 47KB)||09/11/2014|
|14||Carer||Submission 14 (PDF 4.7MB)||09/11/2014|
|15||AstraZeneca||Submission 15 (PDF 92KB)||09/11/2014|
|16||uniQure Biopharma B.V.||Submission 16 (PDF 4MB)||10/11/2014|
|17||Shire Australia||Submission 17 (PDF 171KB)||10/11/2014|
|18||Non-Government Organisation||Not for publication||10/11/2014|
|19||Vertex Pharmaceuticals||Submission 19 (PDF 516KB)||10/11/2014|
|20||Rare Voices Australia||Submission 20 (PDF 525KB)||10/11/2014|
|21||Office of Population Health Genomics and Genetic Services (WA Department of Health)||Submission 21 (PDF 187KB)||10/11/2014|
|22||Consumer||Not for publication||10/11/2014|
|23||The McKell Institute||Submission 23 (PDF 1.6MB)||10/11/2014|
|24||Medicines Australia||Submission 24 (PDF 4.9MB)||10/11/2014|
|25||The Cancer Drugs Alliance||Submission 25 (PDF 169KB)||10/11/2014|
|26||Mucopolysaccharide & Related Diseases Society Australia Ltd||Submission 26 (PDF 211KB)||10/11/2014|
|27||Genzyme, A Sanofi Company||Not for publication||10/11/2014|
|28||Australasian Society of Inborn Errors of Metabolism||Submission 28 (PDF 770KB)||10/11/2014|
|29||GlaxoSmithKline||Submission 29 (PDF 115KB)||10/11/2014|
|30||Alexion Pharmaceuticals Australasia||Not for publication||11/11/2014|
|31||The Society of Hospital Pharmacists Australia||Submission 31 (PDF 115KB)||14/11/2014|